The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The drug discovery market has witnessed remarkable growth, driven by technological innovations and increasing healthcare expenditures. This blog delves into the current market dynamics, future projections, and transformative trends revolutionizing drug discovery processes.

Current Market Scenario

Market Size and Growth

• 2023-2024 Growth:
  • Market size surged from $98.01 billion in 2023 to $111.48 billion in 2024.
  • Achieved a compound annual growth rate (CAGR) of 13.7%.
• Key Growth Factors:
  • Advancements in genomics and proteomics.
  • Expanding prevalence of chronic diseases.
  • Emergence of biopharmaceuticals.

Future Market Projections

Anticipated Growth

• Forecast for 2028:
  • Market projected to reach $192.2 billion in 2028.
  • Expected CAGR of 14.6%.
• Drivers of Growth:
  • Precision medicine adoption.
  • Focus on rare diseases and personalized therapies.

View More On The Drug Discovery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Driving Forces Behind Market Growth

Surge in Healthcare Expenditure

• Impact on Market:
  • Rising healthcare spending globally drives investment in drug discovery.
  • Increasing need for innovative drugs to treat emerging diseases.
  • Healthcare expenditure accounted for 17.3% of the US GDP in 2022.

Transformative Technological Innovations

Imaging Technology

• Enhanced Visualization:
  • Non-invasive imaging technologies aid in understanding biological activities.
  • Crucial for disease comprehension and treatment development.
  • Imaging advancements accelerate drug discovery timelines.

Artificial Intelligence (AI)

• Accelerated Drug Discovery:
  • AI-powered tools streamline target identification and lead optimization.
  • Google Cloud’s AI-powered suites facilitate precision medicine and target identification.

Market Consolidation Through Strategic Acquisitions

Inotiv’s Acquisition of Plato BioPharma

• Expansion of Service Portfolio:
  • Inotiv strengthens drug discovery services with Plato BioPharma acquisition.
  • Comprehensive range of contract research services for drug discovery and preclinical development.
  • Plato BioPharma’s expertise in in vivo pharmacology enhances Inotiv’s capabilities.

Market Segmentation

Comprehensive Classification

• By Drug Type:
  • Small Molecule.
  • Large Molecule.
• By Process:
  • Target Selection.
  • Target Validation.
  • Hit-To-Lead Identification.
  • Lead Optimization.
  • Candidate Validation.
• By Technology:
  • High Throughput Screening.
  • Spectroscopy.
  • Combinatorial Chemistry.
  • Biochips.
  • Pharmacogenomics And Pharmacogenetics.
  • Bioinformatics.
  • Metabolomics.
  • Nanotechnology.
  • Other Technologies.
• By Therapeutic Area:
  • Oncology.
  • Neurology.
  • Infectious and Immune System Diseases.
  • Digestive System Diseases.
  • Cardiovascular Diseases.
  • Diabetes.
  • Respiratory Disease.
  • Other Therapeutic Areas.
• By End User:
  • Pharmaceutical Companies.
  • Contract Research Organizations (CROs).
  • Other End-Users.

Regional Insights

• North America:
  • Largest region in the drug discovery market in 2023.
• Asia-Pacific:
  • Expected to be the fastest-growing region in the forecast period.

As drug discovery continues to evolve, fueled by technological breakthroughs and strategic collaborations, it paves the way for innovative therapies and improved patient outcomes. With a focus on precision medicine and rare diseases, the future of drug discovery holds immense promise for transforming healthcare delivery worldwide.

Request A Sample Of The Global Drug Discovery Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7746&type=smp